Access cutting-edge chronic graft versus host disease treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Seattle location
Access chronic graft versus host disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic graft versus host disease treatment provided free
Check if you qualify for this chronic graft versus host disease clinical trial in Seattle, WA
No-Cost Study Care
Local to Seattle
Convenient for WA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial compares the effect of belumosudil to a placebo in treating patients with chronic graft versus host disease. Chronic graft versus host disease remains a major complication of stem cell transplantation and can involve multiple organ systems. Belumosudil is a ROCK2 selective inhibitor that works to reduce the immune system response causing the chronic graft versus host disease. Giving belumosudil may better treat patients with chronic graft versus host disease and prevent the n
Sponsor: Fred Hutchinson Cancer Center
Yes, this clinical trial (NCT05996627) has an active research site in Seattle, WA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic graft versus host disease treatment options in Seattle, WA, this clinical trial (NCT05996627) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic graft versus host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic graft versus host disease clinical trials near you to find additional studies recruiting in your area.
See all atrial fibrillation clinical trials recruiting in Seattle — not just this study.
Browse Atrial Fibrillation Trials in Seattle →